Skip to main content
Epidemiology and Infection logoLink to Epidemiology and Infection
. 2019 Nov 26;147:e305. doi: 10.1017/S0950268819001869

Toxoplasma gondii infection in children with lymphoma in Eastern China: seroprevalence, risk factors and case–control studies

Yuhe Duan 1,*, Yunlai Zhi 2,*, Yusheng Liu 1, Na Zhou 1, Fujiang Li 1, Xiwei Hao 1, Xiangyan Zhang 3, Qian Dong 1,, Lili Chen 4,
PMCID: PMC7003632  PMID: 31767044

Abstract

Epidemiological data for Toxoplasma gondii regarding malignancy have gained increasing attention; however, the information about T. gondii infection among children with malignant lymphoma (ML) in China is unclear. Therefore, 314 children with lymphoma and 314 healthy children, age- and gender-matched, were recruited to estimate the seroprevalence of T. gondii in the participants and identify the risk factors of infection. Blood samples from all participants were collected and examined for T. gondii IgG and IgM antibodies using ELISA. The results showed that the overall seroprevalence of T. gondii antibodies (including IgG and/or IgM) in ML patients and healthy controls was 19.8% and 9.9%, respectively. Contact with the cats, consumption of oysters and history of chemotherapy were estimated to be the risk factors for T. gondii infection in children with lymphoma by multivariable logistic regression analysis, whereas in healthy children, contact with cats and consumption of oysters were the risk factors. Moreover, among various histological types of lymphoma, individuals with NK/T-cell lymphoma, B-small lymphocytic lymphoma, marginal zone B-lymphoma and Hodgkin's lymphoma had a higher seroprevalence than healthy controls (P < 0.05). These findings indicated the high prevalence of T. gondii infection in children with lymphoma, and hence, efforts should be performed to evaluate the effect of the infection further in lymphoma patients.

Key words: Children, lymphoma, risk factors, seroprevalence, Toxoplasma gondii

Introduction

Toxoplasma gondii is an apicomplexan parasite that infects approximately one-third of the world population [1]. Humans are infected with T. gondii mainly by ingesting cysts from unsanitary food, ingesting food contaminated with cat-derived T. gondii oocysts, as well as transmission from mother to the foetus [2].

Efficient immunity can limit the relapse of T. gondii infection in the multiplying tachyzoite stage, and hence, acute infection is usually asymptomatic in immunocompetent individuals. However, for the immunocompromised host, the cysts can infect various organs, such as the liver, spleen and nervous system, which, in turn, cause severe symptoms as well as death [3, 4]. Currently, T. gondii infection in patients with malignancy is of great concerns, and thus, the correlations between T. gondii infection and malignancy have been evaluated [57].

Malignant lymphoma (ML) is a common malignancy in children, with more than 13 000 new cases and 1800 disease-related deaths in China in 2015 [8]. The genetic, physical and chemical factors are responsible for the development of lymphoma [9, 10]. Also, a potential correlation between T. gondii infection and lymphoma has been reported [1113]; however, a study conducted by Stamatovic et al. did not show any such association [14], thereby rendering it controversial. A few reports have focused on T. gondii infection among children with ML in Eastern China, but little is known about the potential risk factors in this group. Thus, the present study was conducted to explore the seropositivity and risk factors associated with T. gondii infection in children with ML.

Methods

Subjects

Children with ML were followed up and agreed to participate in this study from July 2012 to October 2018. A total of 314 children with primary ML, who presented to the Affiliated Hospital of Qingdao University, were recruited. In addition, 314 healthy children, age-, gender- and residence-matched to the ML patients, were recruited as controls. None of the participants received intravenous immunoglobulin therapy and/or immunotherapy before enrolment. Written informed consent was obtained from all participants/guardians. The study was approved by the Ethics Committee of the Affiliated Hospital of Qingdao University (No. 201311683).

Sample and data collection

Approximately 2 ml of venous blood was withdrawn from the participants. Blood samples were left at room temperature for 2 h to allow clotting, followed by centrifugation at 3000 rpm for 10 min. The sera were collected in and stored at −80 °C until further analysis.

Socio-demographic and clinical data

A structured questionnaire was employed to obtain information about the socio-demographic data, including age; gender; residence area; any history of contact with cats, dogs and swine; consumption of raw/undercooked meat, raw vegetables, fruits and oysters; the source of drinking water; and the parents' occupation [15]. Clinical data collected from the medical examination records encompass the infection status of the mother during pregnancy, history of blood transfusion, chemotherapy and the histological type of ML. Participants/guardians did not know the infection status before the data were collected.

Serological assay

T. gondii antibodies (including IgG and IgM) in sera were tested using the commercially available enzyme immunoassay kits (ELISA) (Demeditec Diagnostics GmbH, Germany) according to the manufacturer's instructions. Sera from the ML patients and healthy children were randomly mixed. Positive and negative controls were included in every assay [15].

Statistical analysis

The results were analysed using the statistical software SPSS 19.0. For the single variable analysis, χ2chi-square test or Fisher's exact test was used to assess the association between T. gondii seroprevalence and various variables. The risk factors associated with T. gondii infection were defined by a multivariable backward stepwise logistic regression analysis. Adjusted odds ratio (OR) with 95% confidence interval (CI) were calculated to identify the effect size of risk factors. A P-value < 0.05 was considered statistically significant in the multivariate analysis.

Results

Socio-demographic and risk factors of ML children with T. gondii infection

The overall seroprevalence of T. gondii antibodies in ML patients and healthy controls was 62/314 (19.8%) and 31/314 (9.9%) (P = 0.001), respectively. A significant difference (P = 0.001) was detected while comparing the seroprevalence of T. gondii IgG antibodies between children with ML and healthy children, i.e. 60 ML children (19.1%) vs. 31 (9.9%) control subjects. Interestingly, we found 13 (4.1%) ML patients and six (1.91%) healthy children positive for IgM antibodies (P = 0.103). The baseline data, including socio-demographic and clinical treatment, are shown in Table 1. In ML patients, the seroprevalence of T. gondii was higher in 11–14-year-old patients (13/50, 26%) than in those ⩽2-year-old (7/47, 14.89%), although a not statistically significant difference was detected (P = 0.18).

Table 1.

Seroprevalence of T. gondii infection in children with lymphoma and control subjects in eastern China

Children with lymphoma(N = 314) Controls (N = 314)
Variable Prevalence of T. gondii infection Prevalence of T. gondii infection
No. tested No. positive % P No. tested No. positive % P
Age (years)
⩽2 47 7 14.9 Reference 50 0 0.0 Reference
3–6 123 21 17.1 0.73 122 14 11.5 0.011a
7–10 94 21 22.3 0.29 88 10 11.4 0.014a
11–14 50 13 26.0 0.18 54 7 13.0 0.013
Gender
Male 116 25 21.6 0.54 124 13 10.5 0.77
Female 198 37 18.7 190 18 9.5
Residence area
Urban 140 28 20.0 0.92 231 25 10.8 0.35
Rural 174 34 19.5 83 6 7.2
Contact with cats
Yes 129 36 27.9 0.002 118 18 15.3 0.01
No 185 26 14.1 196 13 6.6
Contact with dogs
Yes 88 16 18.2 0.66 52 5 9.6 0.95
No 226 46 20.3 262 26 9.9
Contact with swine
Yes 51 7 13.7 0.24 42 4 9.5 0.98a
No 263 55 20.9 272 27 9.9
Consumption of raw/undercooked meat
Yes 47 10 21.3 0.78 66 4 6.1 0.24
No 267 52 19.5 248 27 10.9
Consumption of raw vegetables
Yes 249 50 20.1 0.77 218 22 10.1 0.84
No 65 12 18.5 96 9 9.4
Consumption of oysters
Yes 187 44 23.5 0.04 177 23 13.0 0.04
No 127 18 14.2 137 8 5.8
Source of drinking water
Tap 225 47 20.9 0.42 227 23 10.1 0.80a
Well + river 89 15 16.9 87 8 9.2
Parent's occupation
Farmer 168 34 20.2 0.81 150 18 12.0 0.23a
Worker 146 28 19.2 164 13 7.9
Infection status of mothers during pregnancy
Yes 16 3 18.8 0.73a 44 6 13.6 0.57
No 115 19 16.5 68 12 17.7
Unknown 183 202
Blood transfusion history
Yes 207 40 19.3 0.79
No 107 22 20.6
Chemotherapy history
Yes 216 52 24.1 0.004
No 98 10 10.2
a

Fisher's exact test was used.

Multivariable analysis revealed that contact with cat (OR 2.5; 95% CI 1.4–4.5; P = 0.002), consumption of oysters (OR 1.9; 95% CI 1.1–3.6; P = 0.035) and history of chemotherapy (OR 2.2; 95% CI 0.88–4.2; P = 0.031) were significantly associated with T. gondii infection in ML patients, whereas in healthy controls, contact with cat (OR 2.5; 95% CI 1.2–5.4; P = 0.017) and consumption of oysters (OR 2.4; 95% CI 1.0–5.6; P = 0.042) were the risk factors for the infection (Table 2). Other variables did not show an association with T. gondii infection in the present study.

Table 2.

Multivariable analysis of children with lymphoma and healthy controls and the association with T. gondii infection

Variablea Children with lymphoma Healthy controls
ORb 95% CI P ORb 95% CI P
Contact with cats 2.5 1.4–4.5 0.002 2.5 1.2–5.4 0.017
Consumption of oysters 1.9 1.1–3.6 0.035 2.4 1.0–5.6 0.042
History of chemotherapy 2.2 0.9–4.2 0.031
a

Backwards stepwise multivariable analysis.

b

Adjusted by age.

Seropositivity of T. gondii in children with ML

Table 3 shows the seroprevalence of different histological type of ML. The maximal seroprevalence of T. gondii antibodies was detected in children with NK/T-cell lymphoma (38.46%), followed by B-small lymphocytic lymphoma (30.77%), marginal zone B-lymphoma (25.58%) and diffuse large B-cell lymphoma (21.05%). Compared to the control subjects, patients with NK/T-cell lymphoma, B-small lymphocytic lymphoma, marginal zone B-lymphoma and Hodgkin's lymphoma have significantly higher seroprevalence (all P < 0.05).

Table 3.

Clinical diagnosis and seroprevalence of T. gondii in children with lymphoma in eastern China

Clinical diagnosis No. tested No. positive % OR (95% CI) P
Hodgkin's lymphoma 172 32 18.6 2.1 (1.2–3.6) 0.006
NK/T-cell lymphoma 13 5 38.5 5.7 (1.8–18.8) 0.001
Marginal zone B-lymphoma 43 11 25.6 3.1 (1.4–6.8) 0.003
Mantle cell lymphoma 12 1 8.3 0.8 (0.1–6.6) 0.670
Diffuse large B-cell lymphoma 19 4 21.1 2.4 (0.8–7.8) 0.126
T-cell lymphoma 17 1 5.9 0.6 (0.1–4.5) 0.496
Follicular lymphoma 19 3 158 1.7 (0.5–6.2) 0.304
B-small lymphotic lymphoma 13 4 30.8 4.1 (1.2–13.9) 0.039
Other 6 1 16.7 1.8 (0.2–16.1) 0.470

As compared with 9.9% seroprevalence of T. gondii antibodies in controls (31/314).

Discussion

The genetic, physical and chemical factors are known to be responsible for the development of lymphoma [9, 10]. Although some reports have revealed a possible association between T. gondii infection and lymphoma [1113], the infection status of T. gondii in children with lymphoma remains unclear. Therefore, we tested the T. gondii antibodies, i.e. IgG and IgM in 314 children with lymphoma and 314 healthy controls to explore the seroprevalence and risk factors associated with T. gondii infection in children with ML.

In this study, we found a higher seroprevalence of T. gondii IgG antibodies in children with lymphoma as compared to the control subjects (19.1% vs. 9.9%, P = 0.001), suggesting that the exposure to T. gondii is common in children with lymphoma. However, the seroprevalence of T. gondii IgM antibodies was not significantly different between children with ML and the controls. Reportedly, T. gondii IgG antibodies present later than IgM antibodies in the blood, suggesting a recent infection of T. gondii [16]. IgM can persist for several years, and in the presence of a positive IgM result, caution must be exercised since a chronic T. gondii infection can be erroneously classified as an acute or false positive; in such cases, IgG avidity tests are crucial [17]. In the current study, two lymphoma patients with IgM antibodies solely were diagnosed with toxoplasmosis according to the clinical features and IgG avidity tests. This result was similar to a study conducted by Zhou et al. [15]. Thus, it is necessary to notify the doctors to focus on the significance of T. gondii IgM seropositivity in children with malignancy, and patients with solely T. gondii IgM antibodies should be tested for IgG avidity to avoid misdiagnosis.

Several studies have demonstrated that the positive T. gondii antibodies increased with age in healthy children, but in young patients with malignancy, T. gondii is likely to occur [5, 15, 18]. This could be attributed to the fact that younger patients with malignancy may be immunocompromised and are inclined towards the T. gondii infection [5, 6]. However, the reasons that younger ML patients were susceptible to T. gondii infection have not been well explained, thereby necessitating further investigation.

In the present study, the multivariate logistic analysis showed that contact with cat and consumption of oocysts are associated with the T. gondii infection. Interestingly, felines are the only definitive hosts for T. gondii, and oocytes can be transmitted via cat faeces and cause toxoplasmosis if the oocyst passed by this method was ingested by humans [1]. Some studies also demonstrated that contact with cats was a risk factor for T. gondii infection in patients with malignancy [5, 6]. Moreover, oocysts shed by felines can be washed into the sea by rain, and T. gondii oocysts can be maintained in the sea for many years [19]. If these oocysts were ingested by oysters, it might be a potential risk factor for the transmission of T. gondii. Qingdao is a coastal city, and oysters are a popular snack for people, and hence, the consumption of oysters might increase the possibility of T. gondii infection in patients with malignancy [6]. Therefore, publicizing the information of this risk factor could be conducive to prevent T. gondii infection. In addition, recent studies in Shandong province showed that contact with cats and consumption of undercooked oysters were the risk factors for T. gondii in oral cancer patients [6], and contact with cats and consumption of undercooked meat could increase the risk of T. gondii infection in patients with diabetes mellitus [20]. These similar results indicate the necessity to conduct an epidemiological investigation to identify the risk factors for T. gondii infection in different diseases.

Previous studies demonstrated that blood transfusion was a risk factor for T. gondii infection in patients with malignancy [6, 15, 21]. In the current study, we found among many clinical variables, the seroprevalence of T. gondii was only associated with the history of chemotherapy. Chemotherapy is not only an effective treatment for lymphoma but also suppresses the patients' immune system, which would render them vulnerable to T. gondii. Moreover, some studies also demonstrated that chemotherapy augments the infection risk of T. gondii [22, 23]. Thus, T. gondii infection should be monitored in children with lymphoma; if toxoplasmosis was confirmed, microbiotic antibiotic, such as sulfamethoxazole, should be administered to prevent toxoplasmosis [15].

Among the various histological types of lymphoma, the seroprevalence of T. gondii in aggressive lymphomas, such as NK/T-cell lymphoma, B-small lymphocytic lymphoma, marginal zone B-lymphoma and Hodgkin's lymphoma, was significantly higher than that in the controls. However, patients with indolent lymphoma present a lower seroprevalence of T. gondii as compared to the controls, which was consistent with the current findings [23]. Some reports showed a potential association between T. gondii infection and non-Hodgkin's lymphoma [11], intraocular B-cell lymphoma [12] and B-cell lymphoproliferative disorders [23]. Also, T. gondii can dysregulate the immune response pathway and reduce lipid synthesis by downregulating the activity of butyrylcholinesterase [24, 25]. In addition, the infection of T. gondii RH strain contributes to the high levels of T helper cell type 1 (Th1) cytokine and a robust inflammatory response and breaks the balance between apoptosis and anti-apoptosis [26, 27], thereby leading to an imbalance in the hosts' gene expression, which would result in carcinogenesis [28].

Nonetheless, aggressive chemotherapy and immunosuppressive therapeutics used for treating the patients suffering from aggressive lymphoma cause deficiency in cell-mediated immunity; therefore, these patients were at risk to T. gondii infections and inclined to manifest toxoplasmosis [15]. This phenomenon could partially explain the high seroprevalence of the infection in aggressive lymphoma patients. However, further studies are needed to explore the causes of the difference in the seroprevalence in various histological types of lymphoma.

Nevertheless, the present study has some limitations. First, the limited data did not represent the whole of China. Second, the treatment data of the patients were lacking, and hence, the influence of immunosuppressive management for antibody seroprevalence was uncertain. Third, the donors' sera were not tested, and thus, the influence of the donor-derived antibody was unclear.

Conclusion

The present study revealed that T. gondii infection is prevalent in children with lymphoma, and contact with cats, consumption of raw oysters and history of chemotherapy were independently associated with the risk of infection in this patient group. Thus, the clinicians should be careful with this pathogen infection in patients with lymphoma and efforts should be directed towards evaluating the effect of T. gondii in lymphoma patients.

Acknowledgments

Conflict of interest

The authors declare that there are no conflicts of interest.

Financial support

This study was supported by the Shandong Provincial Natural Science Foundation, China (ZR2016HQ18). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Supplementary material

For supplementary material accompanying this paper visit https://doi.org/10.1017/S0950268819001869.

S0950268819001869sup001.docx (14.1KB, docx)

click here to view supplementary material

References

  • 1.Montoya JG and Liesenfeld O (2004) Toxoplasmosis. The Lancet 363, 1965–1976. [DOI] [PubMed] [Google Scholar]
  • 2.The Lancet Infectious Diseases (2012) Toxoplasma gondii: an unknown quantity. The Lancet Infectious Diseases 12, 737–737. [DOI] [PubMed] [Google Scholar]
  • 3.Nimir A et al. (2010) Latent toxoplasmosis in patients with different malignancy: a hospital based study. Journal of Clinical Medicine Research 2, 117–120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ferreira MS and Borges AS (2002) Some aspects of protozoan infections in immunocompromised patients – a review. Memorias do Instituto Oswaldo Cruz 97, 443–457. [DOI] [PubMed] [Google Scholar]
  • 5.Cong W et al. (2015) Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer Letters 359, 307–313. [DOI] [PubMed] [Google Scholar]
  • 6.Zhou N et al. (2018) Seroprevalence and risk factors of Toxoplasma gondii infection in oral cancer patients in China: a case–control prospective study. Epidemiology and Infection 146, 1891–1895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Alvaradoesquivel C et al. (2010) Seroepidemiology of Toxoplasma gondii infection in patients with vision and hearing impairments, cancer, HIV, or undergoing hemodialysis in Durango, Mexico. Journal of Parasitology 96, 505–508. [DOI] [PubMed] [Google Scholar]
  • 8.Chen W et al. (2016) Cancer statistics in China, 2015. CA: A Cancer Journal for Clinicians 66, 115–132. [DOI] [PubMed] [Google Scholar]
  • 9.Hoppe RT et al. (2014) Hodgkin Lymphoma. Journal of the National Comprehensive Cancer Network 9, 1020–1058. [DOI] [PubMed] [Google Scholar]
  • 10.Ferlay J et al. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 136, E359–E386. [DOI] [PubMed] [Google Scholar]
  • 11.Herold MA et al. (2009) Disseminated toxoplasmosis in a patient with non-Hodgkin lymphoma. Infection 37, 551–554. [DOI] [PubMed] [Google Scholar]
  • 12.Shen DF et al. (2001) Detection of Toxoplasma gondii DNA in primary intraocular B-cell lymphoma. Modern Pathology 14, 995–999. [DOI] [PubMed] [Google Scholar]
  • 13.Hashiguchi J and Onozawa M (2018) Re-infection of Toxoplasma gondii after HSCT presenting lymphadenopathy resembling recurrence of lymphoma. Transplant Infectious Disease 20, e12892–e12895. [DOI] [PubMed] [Google Scholar]
  • 14.Stamatovic L et al. (1999) Is Toxoplasma gondii opportunistic infection in patients with malignant lymphoma a major problem? BMC Genomics 9, 111–115. [Google Scholar]
  • 15.Zhou N et al. (2019) Seroprevalence and risk factors of Toxoplasma gondii infection in children with leukemia in Shandong Province, Eastern China: a case–control prospective study. PeerJ 7, e6604–e6611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Liesenfeld O et al. (2001) Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. Journal of Infectious Diseases 183, 1248–1253. [DOI] [PubMed] [Google Scholar]
  • 17.Reshika D et al. (2015) Significance of a positive toxoplasma immunoglobulin M test result in the United States. Journal of Clinical Microbiology 53, 3601–3605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Marchioro AA et al. (2015) Risk factors associated with toxoplasmosis and toxocariasis in populations of children from nine cities in southern Brazil. Journal of Helminthology 89, 428–432. [DOI] [PubMed] [Google Scholar]
  • 19.Dubey JP (2004) Toxoplasmosis – a waterborne zoonosis. Veterinary Parasitology 126, 57–72. [DOI] [PubMed] [Google Scholar]
  • 20.Li Y-X et al. (2018) Toxoplasma gondii infection in diabetes mellitus patients in China: seroprevalence, risk factors, and case-control studies. BioMed Research International 4, 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Alvarado-Esquivel C et al. (2018) Association between Toxoplasma gondii infection and history of blood transfusion: a case-control seroprevalence study. Journal of International Medical Research 46, 1626–1634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ortiz-Munoz AB et al. (1984) [Possible interactions between Toxoplasma gondii infection and the presence of non-Hodgkin's lymphoma]. Revista espanola de oncologia 31, 237–245. [PubMed] [Google Scholar]
  • 23.Scerra S et al. (2013) Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review. European Journal of Clinical Microbiology & Infectious Diseases 32, 1259–1268. [DOI] [PubMed] [Google Scholar]
  • 24.He JJ et al. (2016) Proteomic profiling of mouse liver following acute Toxoplasma gondii Infection. PLoS ONE 11, e0152022–e0152037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Da Silva AS et al. (2013) Relationship between butyrylcholinesterase activity and liver injury in mice acute infected with Toxoplasma gondii. Pathology Research & Practice 209, 95–98. [DOI] [PubMed] [Google Scholar]
  • 26.Mordue DG et al. (2001) Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. Journal of Immunology 167, 4574–4584. [DOI] [PubMed] [Google Scholar]
  • 27.He JJ et al. (2015) Analysis of miRNA expression profiling in mouse spleen affected by acute Toxoplasma gondii infection. Infection Genetics & Evolution Journal of Molecular Epidemiology & Evolutionary Genetics in Infectious Diseases 37, 137–142. [DOI] [PubMed] [Google Scholar]
  • 28.Gharavi MJ et al. (2017) Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients. Veterinary World 10, 1063–1065. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

For supplementary material accompanying this paper visit https://doi.org/10.1017/S0950268819001869.

S0950268819001869sup001.docx (14.1KB, docx)

click here to view supplementary material


Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES